Featuring sector and linear arrays, the FDA-cleared Vscan Air SL ultrasound device reportedly enables cardiac and vascular assessments at the point of care.
Offering a combination of proprietary image enhancing technology and the ability to switch between vascular and cardiac assessments with one device at the point of care, GE HealthCare has launched the handheld ultrasound device Vscan Air SL at the European Society of Cardiology (ESC) Congress in Amsterdam, the Netherlands.
Emphasizing the proprietary SignalMax and XDclear technologies available with Vscan Air SL, GE HealthCare said the handheld ultrasound device offers enhanced sensitivity and resolution.
The dual-headed probe of Vscan Air SL also enables clinicians to access sector and linear arrays on the same device, a capability that facilitates rapid vascular and cardiac assessments of patients, according to GE HealthCare.
“Having ever more powerful handheld ultrasound is a game changer for patient care. Whether on the ward or in general practice, being able to provide high-quality imaging at the point of care means rapid diagnosis and rapid treatment,” noted Guy Lloyd, M.D., FRCP, a consultant cardiologist at Barts Heart Center and University College London Hospitals.
GE HealthCare noted that Vscan Air SL, which has garnered FDA 510(k) clearance, will be commercially available in the United States within the next month. The device is currently available in Austria and New Zealand as well as countries in Asia and Europe, according to the company.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.